| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Gopi Shankar is Chief Development Officer at LRMR. Gopi Shankar's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $194K at current prices.
Net of sales, the LRMR filings show accumulation of 5,000 shares.
Gopi Shankar has 5 Form 4 filings on record from February 2023 to January 2026, all as Chief Development Officer at Larimar Therapeutics (LRMR), 2023–2026.
The 8 reported transactions were 4 option or other derivative awards, 3 stock awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $19K and no sales.
The only open-market purchase was 5,000 shares of LRMR at an average $3.73 on December 7, 2023, about $19K. Twelve months later LRMR was up 77%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | LRMR Larimar Therapeutics, Inc. | Chief Development Officer | Buy | 5,000 | $3.73 | $18,661.50 | New | +208.8% | +77.5% |